Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glioblastoma (GB) are aggressive tumors that obstruct normal brain function. While the skull cannot expand in response to cancer growth, the growing pressure in the brain is generally the first sign. It can produce more frequent headaches, unexplained nausea or vomiting, blurred peripheral vision, double vision, a loss of feeling or movement in an arm or leg, and difficulty speaking and concentrating; all depend on the tumor’s location. GB can also cause vascular thrombi, damaging endothelial cells and leading to red blood cell leakage. Latest studies have revealed the role of single nucleotide polymorphisms (SNPs) in developing and spreading cancers such as GB and breast cancer. Many discovered SNPs are associated with GB, particularly in great abundance in the promoter region, creating polygenetic vulnerability to glioma. This study aims to compile a list of some of the most frequent and significant SNPs implicated with GB formation and proliferation.

Cite

CITATION STYLE

APA

Mukerjee, N., Maitra, S., Roy, S., Modak, S., Hasan, M. M., Chakraborty, B., … Alexiou, A. (2023, January 1). Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme. Metabolic Brain Disease. Springer. https://doi.org/10.1007/s11011-022-01082-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free